DOCS Jan 2025 47.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.3000

0.0000

(0.00%)

As of 10:15AM EDT. Market open.

Loading interactive chart…

Zacks
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
Organon (OGN) delivered earnings and revenue surprises of 25.77% and 3.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
Elevance Health, Medpace and Doximity are part of the Zacks Industry Outlook article.
Business Wire
Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
SAN FRANCISCO, April 25, 2024--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.